Platelet-activating factor decreases skin keratinocyte tight junction barrier integrity - 18/04/17
Doi : 10.1016/j.jaci.2016.05.037
Su Duan, MD a, b, c, ∗, Kerstin Wanke, PhD a, b, ∗, Paulina Wawrzyniak, MSc a, b, Yifan Meng, MD a, b, c, Jeannette I. Kast, MSc a, b, Beate Rückert, Sci Tec a, b, Ana Rebane, PhD a, b, d, Mu Xian, MD a, b, e, Carsten Bindslev-Jensen, MD, PhD, DMSci f, Sigurd Broesby-Olsen, MD, PhD, DMSci f, Ulrike Raap, MD g, Thomas Werfel, MD g, Mübeccel Akdis, MD, PhD a, b, Luo Zhang, MD c, e, h, Cezmi A. Akdis, MD a, b 
a Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland
b Christine Kühne-Center for Allergy Research and Education, Davos, Switzerland
c Department of Allergy, Beijing Tongren Hospital, Capital Medical University, Beijing, China
d Molecular Pathology, Faculty of Medicine, University of Tartu, Tartu, Estonia
e Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Key Laboratory of Otolaryngology Head and Neck Surgery (Capital Medical University), Ministry of Education, Beijing, China
f Department of Dermatology and Allergy Centre, Odense University Hospital, Odense, Denmark
g Department of Dermatology and Allergy, Division of Immunodermatology and Allergy Research, Hannover Medical School, Hannover, Germany
h Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, Beijing, China
| The authors' laboratories are supported by the Swiss National Science Foundation (grant nos. 310030-156823 and 320030-159870) and the Christine Kühne-Center for Allergy Research and Education and Swiss Polish Research Programme (grant no. PSPB-072/2010). |
|
| Disclosure of potential conflict of interest: C. A. Akdis serves as a consultant for Actellion, Aventis, Stallergenes, Allergopharma, and Ciracia; is an employee of Swiss Institute of Allergy and Asthma Research, University of Zurich, Switzerland; receives grant support from Novartis Research on immunoregulation in asthma, PREDICTA: European Commission's Seventh Framework Programme No. 260895 Research on virus-induced exacerbations, Swiss National Science Foundation Research on T-cell interaction with the epithelium, MeDALL: European Commission's Seventh Framework Programme No. 261357 Research on early initiation of asthma, and Christine Kühne-Center for Allergy Research and Education Research on severe allergies. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2016
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 138 - N° 6
P. 1725 - décembre 2016 Retour au numéro
Article précédent
- Variable phenotype and discrete alterations of immune phenotypes in CTP synthase 1 deficiency: Report of 2 siblings
- Johannes Trück, Dominic F. Kelly, John M. Taylor, Anne Kathrin Kienzler, Tracy Lester, Anneke Seller, Andrew J. Pollard, Smita Y. Patel
- Linear epitope mapping of peanut allergens demonstrates individualized and persistent antibody-binding patterns
- Christian S. Hansen, Martin Dufva, Katrine L. Bøgh, Eric Sullivan, Jigar Patel, Thomas Eiwegger, Zsolt Szépfalusi, Morten Nielsen, Anders Christiansen
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?